FDA Accepts Neurocrine's Resubmitted Application for Insomnia Drug
Monday, September 3, 2007
A resubmitted new drug application for an insomnia treatment developed by Neurocrine Biosciences Inc...
Take 1 minute to subscribe and you'll get this story immediately, plus:
Already a subscriber? Sign in
- 52 weekly issues
- Subscriber-only digital content every business day, plus full access to SDBJ.com archives
- Book of Lists — the most comprehensive business resource in San Diego
- San Diego 500 — influential business leaders you need to know